Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,188.5
-9.6 (-0.30%)

 

  • STI Straits Times Index
    3,188.5
    -9.6 (-0.30%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,591.6
    -14.7 (-0.92%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,017.5
    -118.5 (-0.45%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,594.8
    7.8 (0.22%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,708.6
    -547.0 (-1.87%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,633.0
    -23.0 (-0.35%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,695.9M
  • Value: 946.0M
  • Rise: 169
  • Fall: 162
  • Unch: 420

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
King Wan0.057+0.006
Metal Component0.058+0.006
Hatten Land0.071-0.001
Sinjia Land0.079+0.001
Tritech0.022-0.004
Shen Yao0.003-
Jiutian Chemical0.087-
Rex Intl0.350+0.005
BlackGoldNatural0.021+0.002
Ntegrator Intl0.009-

World Indices

World Indices
Name Last Change
Nasdaq 15,121.7 -7.4
HSI 26,017.5 -118.5
HSCEI 9,273.6 -3.1
Jakarta 6,633.0 -23.0
Nikkei 225 28,708.6 -547.0
SSE Comp 3,594.8 +7.8
Shanghai A 3,767.5 +8.1
Shanghai B 277.5 +1.1
KOSPI 3,007.3 -5.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

GINKGO BIOWORKS HOLDINGS INC GINKGO BIOWORKS HOLDINGS INC CLASS A
Updated on 20 Oct 2021 (End of trading day)
Last (USD): 13.770 Change: -1.040 High: 14.700 Remarks: -
Change (%): -7.02 Low: 13.110
Open 14.590 Yesterday's Close 14.809999999999999
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 6,927,271 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a - Trailing EPS (USD) e - NAV (USD) b 0.7515
PE a - Trailing PE f - Price / NAV b 18.3234
Dividend (USD) d - Cash In Hand (USD) g - Issued & Paid-up Shares c 1,330,070,000
Dividend Yield (%) d - Price / Cash In Hand g - Treasury Shares h -
Market Cap (M) 26,953.219 Enterprise Value (M) 26,953.181
Piotroski F Score - Exchange Code DNA Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 73.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 21 Sep 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 17 Sep 2021.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference GINKGO BIOWORKS HOLDINGS INC NYSE 26,953.219 - - 18.3234 -
Industry Biotechnology NYSE 4,903.176 55.281 158.853 13.4768 -
Local Peer ARCUS BIOSCIENCES INC NYSE 2,440.961 - - 4.0376 -
Local Peer NUVATION BIO INC NYSE 2,051.959 - - 2.6009 -
Local Peer MYOVANT SCIENCES LTD NYSE 1,859.974 - - -4.6543 -
Local Peer AMBRX BIOPHARMA INC SPON ADS EACH REP 7 ORD SHS NYSE 523.983 - - -3.7579 -
Local Peer SQZ BIOTECHNOLOGIES CO NYSE 334.605 - - 2.1912 -
Local Peer ENZO BIOCHEM INC NYSE 157.533 20.004 20.004 2.2968 -
Global Peer MODERNA INC NASDAQ 134,418.154 - 38.461 20.0505 -
Global Peer AMGEN INC HKEx 999,987.372 17.749 22.444 15.6138 2.871
Global Peer CSL LTD ASX 134,263.755 42.170 42.170 12.0266 0.996
Global Peer GILEAD SCIENCES INC NASDAQ 83,829.737 681.549 16.240 4.2547 4.069
Global Peer ILLUMINA INC NASDAQ 64,704.925 98.636 84.251 12.4913 -
Global Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 65,070.588 3,756.030 13.250 10.0077 -
Global Peer WUXI BIOLOGICS (CAYMAN) INC HKEx 479,860.680 252.850 145.383 12.0184 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 60,184.631 17.131 9.699 3.9785 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 48,121.300 17.746 24.161 5.2326 -
Global Peer BIOGEN INC NASDAQ 39,727.727 9.930 20.712 3.6950 -
Other Global Peers BEIGENE LTD (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SEAGEN INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SINO BIOPHARMACEUTICAL (HKEx), INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), NOVAVAX INC (NASDAQ), ACCELERON PHARMA (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED (HKEx), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), GENSCRIPT BIOTECH CORPORATION (HKEx), CRISPR THERAPEUTICS AG (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), FATE THERAPEUTICS (NASDAQ), KODIAK SCIENCES INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), JOINN LABORATORIES (CHINA) CO LTD (HKEx), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ALKERMES PLC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), Lonza (SGX), IONIS PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), 23ANDME HOLDING CO (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), LYELL IMMUNOPHARMA INC (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), INSMED INC (NASDAQ), CYTOKINETICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), 3SBIO INC (HKEx), CHEMOCENTRYX INC (NASDAQ), INSTIL BIO INC (NASDAQ), KINTOR PHARMACEUTICAL LTD (HKEx), ALLOGENE THERAPEUTICS INC (NASDAQ), ALPHAMAB ONCOLOGY (HKEx), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), SEER INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), JACOBIO PHARMACEUTICALS GRP CO LTD (HKEx), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), IMUGENE LIMITED (ASX), ROCKET PHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), VALNEVA SE SPON ADS EACH REPR 2 ORD SHS (NASDAQ), CORTEXYME INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ALLOVIR INC (NASDAQ), VIVA BIOTECH HOLDINGS (HKEx), INHIBRX INC (NASDAQ), KADMON HLDGS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), SHANGHAI HAOHAI BIOLOGICAL TECH CO (HKEx), BIONANO GENOMICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), FRONTAGE HOLDINGS CORP (HKEx), UNIQURE N.V. (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), VAXCYTE INC (NASDAQ), MACROGENICS INC (NASDAQ), CARIBOU BIOSCIENCES INC (NASDAQ), IMMUNOGEN INC (NASDAQ), AGENUS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ASCENTAGE PHARMA GROUP INTL (HKEx), KRYSTAL BIOTECH INC (NASDAQ), MERUS B V (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), MONTE ROSA THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), MAXCYTE INC (NASDAQ), NUVALENT INC (NASDAQ), OMEGA THERAPEUTICS INC (NASDAQ), HUMACYTE INC (NASDAQ), IMMUNOVANT INC (NASDAQ), PRECIGEN INC (NASDAQ), FIBROGEN INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), DICE THERAPEUTICS INC (NASDAQ), RANI THERAPEUTICS HLDGS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), BIOATLA INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), JANUX THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), PERSONALIS INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), IMAGO BIOSCIENCES INC (NASDAQ), IMMATICS N V (NASDAQ), SHATTUCK LABS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), PACIFIC EDGE LIMITED (ASX), JW (CAYMAN) THERAPEUTICS CO. LTD (HKEx), BIOXCEL THERAPEUTICS INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MESOBLAST LTD (ASX), MIMEDX GROUP INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ANAPTYSBIO INC (NASDAQ), GRAPHITE BIO INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), GENOR BIOPHARMA HLDGS LTD (HKEx), AFFIMED N V (NASDAQ), NAUTILUS BIOTECHNOLOGY INC (NASDAQ), CURIS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), MOLECULAR PARTNERS AG SPON ADS EACH REP 1 ORD SHS (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), PLIANT THERAPEUTICS INC (NASDAQ), THESEUS PHARMACEUTICALS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), SERES THERAPEUTICS (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), NKARTA INC (NASDAQ), AADI BIOSCIENCE INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), JASPER THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ALTIMMUNE INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), VERASTEM INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), 22ND CENTURY GROUP INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), GERON CORP (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), EPIZYME INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), ELIEM THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ESSEX BIO-TECHNOLOGY (HKEx), KEZAR LIFE SCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), DPHARMA (Bursa), ASCLETIS PHARMA INC (HKEx), HUMANIGEN INC (NASDAQ), OMEROS CORP (NASDAQ), SINOMAB BIOSCIENCE LTD (HKEx), CUE BIOPHARMA INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), IMMUTEP LTD (ASX), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ANTEOTECH LIMITED (ASX), VERA THERAPEUTICS INC. (NASDAQ), ATHIRA PHARMA INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AEROVATE THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), AKOUOS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), OPTHEA LIMITED (ASX), 9 METERS BIOPHARMA INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), INMUNE BIO INC (NASDAQ), NANOVIRICIDES INC (NYSE American), FORTRESS BIOTECH INC (NASDAQ), LEES PHARMACEUTICAL HLDGS (HKEx), NEOLEUKIN THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ADICET BIO INC (NASDAQ), ONCORUS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), COGNITION THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), AVROBIO INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), XERIS BIOPHARMA HLDGS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), NEXTCURE INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), KAMADA LTD (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), IMMUNOME INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), SESEN BIO INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CARDIOL THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), NEXT SCIENCE LTD (ASX), ATRECA INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), TREVENA INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), LAVA THERAPEUTICS NV (NASDAQ), ELEVATION ONCOLOGY INC (NASDAQ), SYNLOGIC INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), MIROMATRIX MEDICAL INC (NASDAQ), EQUILLIUM INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), GEMINI THERAPEUTIC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CONTRAFECT CORP (NASDAQ), BIOVIE INC (NASDAQ), SAVARA INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 2 ORD SHS (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), CHAMPIONS ONCOLOGY INC (NASDAQ), WANG ON GROUP (HKEx), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), IMV INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), INFLARX N V (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ORGENESIS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), HCW BIOLOGICS INC (NASDAQ), EVOGENE LTD (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), BIONOMICS LTD (ASX), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), IN8BIO INC (NASDAQ), STATERA BIOPHARMA INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), AXCELLA HEALTH INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CEL-SCI CORP (NYSE American), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), OTONOMY INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), EXICURE INC (NASDAQ), LEAF RESOURCES LTD (ASX), GLYCOMIMETICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), METACRINE INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), CAPRICOR THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ASTRIA THERAPEUTICS INC (NASDAQ), IBIO INC (NYSE American), AVALON GLOBOCARE CORP (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), GAIN THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), LUMOS PHARMA INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), CHIMERIC THERAPEUTICS LTD (ASX), ONCONOVA THERAPEUTICS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), UNI-BIO SCIENCE GROUP LIMITED (HKEx), ADVAXIS INC (NASDAQ), LONGEVERON INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIOMX INC (NYSE American), ENDRA LIFE SCIENCES INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), MONOPAR THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), PATRYS LIMITED (ASX), NABRIVA THERAPEUTICS PLC (NASDAQ), RHINOMED LIMITED (ASX), COHBAR INC (NASDAQ), ENSYSCE BIOSCIENCES INC (NASDAQ), VACCINEX INC (NASDAQ), PRECIPIO INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), AZIYO BIOLOGICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), BON NAT LIFE LTD (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), CHIA TAI ENTERPRISES INTL LTD (HKEx), ENDURANCE RP LTD (HKEx), GENETIC TECHNOLOGIES (ASX), DIFFUSION PHARMACEUTICALS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), SOLIGENIX INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), TRANSCODE THERAPEUTICS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), TERRAGEN HOLDINGS LIMITED (ASX), ARCA BIOPHARMA INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ZIVO BIOSCIENCE INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), MEMPHASYS LTD (ASX), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), PALISADE BIO INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ADITX INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), HISTOGEN INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), ORAGENICS INC (NYSE American), BIOTRON (ASX), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), FIRST WAVE BIOPHARMA INC (NASDAQ), GEOVAX LABS INC (NASDAQ), BIOSINO BIO-TECHNOLOGY AND SCIENCE (HKEx), AVECHO BIOTECHNOLOGY LTD (ASX), ALTAMIRA THERAPEUTICS LTD (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ARGENICA THERAPEUTICS LIMITED (ASX), BELLICUM PHARMACEUTICALS (NASDAQ), SENESTECH INC (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), REGENEUS LTD (ASX), XENETIC BIOSCIENCES INC (NASDAQ), ADALTA LTD (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EA REP 400 ORD SHS (NASDAQ), CRYOSITE (ASX), Suntar Eco-City (SGX), CONSTELLATION TECHNOLOGIES LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), NANOLLOSE LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), HAO WEN HOLDINGS LIMITED (HKEx), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+2.140
+18.40 %
10 Days -+2.550
+22.73 %
20 Days -+1.470
+11.95 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 9.130 - 14.880 Change From 1 Year Low +4.640 % Change From 1 Year Low (%) +50.82
Change From 1 Year High -1.110 % Change From 1 Year High (%) -7.46
2 Years Range 9.130 - 14.880 Change From 2 Years Low +4.640 % Change From 2 Years Low (%) +50.82
Change From 2 Years High -1.110 % Change From 2 Years High (%) -7.46
5 Years Range 9.130 - 14.880 Change From 5 Years Low +4.640 % Change From 5 Years Low (%) +50.82
Change From 5 Years High -1.110 % Change From 5 Years High (%) -7.46
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
20 Oct 2021 14.590 14.700 13.110 13.770 6,927,271 -
19 Oct 2021 12.330 14.880 12.170 14.810 15,404,660 -
18 Oct 2021 11.790 12.420 11.400 12.320 6,447,227 -
15 Oct 2021 11.800 12.186 11.310 11.910 7,824,221 -
14 Oct 2021 10.650 11.860 10.570 11.630 6,213,254 -
13 Oct 2021 11.120 11.680 10.240 10.250 4,768,056 -
12 Oct 2021 9.680 11.270 9.640 10.830 16,746,100 -
11 Oct 2021 10.440 10.460 9.440 9.470 5,226,252 -
08 Oct 2021 11.120 11.150 10.320 10.330 9,218,506 -
07 Oct 2021 10.720 11.650 10.590 11.220 20,939,480 -
06 Oct 2021 11.490 11.750 9.130 10.590 60,332,520 -
05 Oct 2021 11.650 12.270 11.370 11.980 6,824,620 -
04 Oct 2021 11.650 11.725 11.250 11.380 12,098,280 -
01 Oct 2021 11.660 11.720 11.200 11.510 9,817,428 -
30 Sep 2021 12.240 12.290 11.410 11.590 7,115,788 -
29 Sep 2021 13.000 13.110 12.010 12.200 7,497,802 -
28 Sep 2021 13.000 13.130 12.150 12.870 8,051,527 -
27 Sep 2021 13.060 13.740 12.880 13.280 6,105,250 -
24 Sep 2021 12.230 12.790 11.910 12.600 3,958,665 -
23 Sep 2021 12.200 12.710 11.850 12.300 5,881,854 -
22 Sep 2021 12.110 12.960 11.780 11.870 7,660,822 -
21 Sep 2021 11.600 12.390 11.380 11.700 8,725,691 -
Summary
Current 2 Weeks
(07 Oct 2021 to 20 Oct 2021)
10.720 14.880 9.440 13.770 99,715,027 -
Previous 2 Weeks
(23 Sep 2021 to 06 Oct 2021)
12.200 14.880 9.440 10.590 127,683,734 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.